Geode Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-432,270
Closed -$188K 4861
2022
Q4
$188K Sell
432,270
-1,116
-0.3% -$362 ﹤0.01% 4136
2022
Q3
$121K Hold
433,386
﹤0.01% 4484
2022
Q2
$156K Buy
433,386
+2,178
+0.5% +$902 ﹤0.01% 4400
2022
Q1
$288K Hold
431,208
﹤0.01% 4198
2021
Q4
$556K Buy
431,208
+37,404
+9% +$66.4K ﹤0.01% 3990
2021
Q3
$854K Sell
393,804
-14,283
-3% -$31.1K ﹤0.01% 3765
2021
Q2
$1.11M Buy
408,087
+360,218
+753% +$896K ﹤0.01% 3535
2021
Q1
$124K Hold
47,869
﹤0.01% 4255
2020
Q4
$133K Buy
47,869
+24,811
+108% +$72.2K ﹤0.01% 4005
2020
Q3
$106K Sell
23,058
-35,255
-60% -$116K ﹤0.01% 3889
2020
Q2
$164K Buy
58,313
+14,088
+32% +$45.2K ﹤0.01% 3713
2020
Q1
$107K Buy
44,225
+8,378
+23% +$30.2K ﹤0.01% 3744
2019
Q4
$183K Buy
35,847
+15,732
+78% +$87.2K ﹤0.01% 3825
2019
Q3
$129K Hold
20,115
﹤0.01% 3891
2019
Q2
$125K Sell
20,115
-1,854
-8% -$14.1K ﹤0.01% 3908
2019
Q1
$233K Buy
21,969
+10,083
+85% +$100K ﹤0.01% 3694
2018
Q4
$94K Buy
11,886
+6,437
+118% +$92.8K ﹤0.01% 3873
2018
Q3
$105K Sell
5,449
-15,910
-74% -$290K ﹤0.01% 3914
2018
Q2
$386K Buy
21,359
+7,502
+54% +$111K ﹤0.01% 3523
2018
Q1
$147K Buy
13,857
+904
+7% +$14.5K ﹤0.01% 3765
2017
Q4
$546K Sell
12,953
-6,576
-34% -$295K ﹤0.01% 3325
2017
Q3
$1.07M Buy
19,529
+12,746
+188% +$2.15M ﹤0.01% 3092
2017
Q2
$1.26M Buy
6,783
+1,621
+31% +$284K ﹤0.01% 2998
2017
Q1
$616K Buy
5,162
+788
+18% +$82.6K ﹤0.01% 3230
2016
Q4
$434K Buy
4,374
+516
+13% +$54.3K ﹤0.01% 3318
2016
Q3
$432K Buy
3,858
+292
+8% +$35.1K ﹤0.01% 3310
2016
Q2
$366K Buy
3,566
+1,716
+93% +$172K ﹤0.01% 3350
2016
Q1
$169 Sell
1,850
-303
-14% -$32.3K ﹤0.01% 3685
2015
Q4
$310K Buy
2,153
+471
+28% +$61.3K ﹤0.01% 3496
2015
Q3
$173K Buy
+1,682
New +$197K ﹤0.01% 3731

Other funds holding SIOX